Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505531 · ClinicalTrials.gov registry record
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 7
- Enrollment target
NCT00505531: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00505531 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505531 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The Massachusetts General Hospital Center for Translational Pain Research is conducting a research study to see if Ultram ER, an FDA-approved pain medication, would be helpful in providing pain relief in subjects whose chronic pain is not well controlled on narcotic pain medicine.
Interventions
- DRUG Benadryl
- DRUG Tramadol Extended Release Oral Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00505531
The ClinicalTrials.gov registry entry for NCT00505531 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Benadryl is the first listed.
NCT00505531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00505531 about?
NCT00505531 is a clinical study titled "Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics". The Massachusetts General Hospital Center for Translational Pain Research is conducting a research study to see if Ultram ER, an FDA-approved pain medication, would be helpful in providing pain relief in subjects whose chronic pain is not well controlled on narcotic pain medicine.
What is the current status of trial NCT00505531?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00505531?
The interventions under investigation include: Benadryl (DRUG), Tramadol Extended Release Oral Capsule (DRUG).
Who is sponsoring clinical trial NCT00505531?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.